US Patent Issued to Variation Biotechnologies on Sept. 23 for "Compositions and methods for treatment of cytomegalovirus" (American, French Inventors)

ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,421,283, issued on Sept. 23, was assigned to Variation Biotechnologies Inc. (Ottawa).

"Compositions and methods for treatment of cytomegalovirus" was invented by David E. Anderson (Newton, Mass.) and Anne-Catherine Fluckiger (Saint Genis les Ollieres, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides compositions and methods useful for treating HCMV infection. As described herein, the compositions and methods are based on development of immunogenic compositions that include virus-like particles (VLPs) which comprise one or more Moloney Murine leukemia virus (MMLV) core proteins and include one or more HCMV epitopes, ...